Kp Tissue Stock Performance
| KPT Stock | CAD 8.94 0.02 0.22% |
On a scale of 0 to 100, KP Tissue holds a performance score of 19. The company owns a Beta (Systematic Risk) of -0.0408, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning KP Tissue are expected to decrease at a much lower rate. During the bear market, KP Tissue is likely to outperform the market. Please check KP Tissue's potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to make a quick decision on whether KP Tissue's current price history will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in KP Tissue are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, KP Tissue displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
| KP Tissue dividend paid on 15th of July 2025 | 07/15/2025 |
| Begin Period Cash Flow | 7 M | |
| Total Cashflows From Investing Activities | 7 M |
KPT |
KP Tissue Relative Risk vs. Return Landscape
If you would invest 784.00 in KP Tissue on April 26, 2025 and sell it today you would earn a total of 110.00 from holding KP Tissue or generate 14.03% return on investment over 90 days. KP Tissue is generating 0.2124% of daily returns assuming 0.8787% volatility of returns over the 90 days investment horizon. Simply put, 7% of all stocks have less volatile historical return distribution than KP Tissue, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
KP Tissue Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for KP Tissue's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as KP Tissue, and traders can use it to determine the average amount a KP Tissue's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2417
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | KPT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.88 actual daily | 7 93% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.24 actual daily | 19 81% of assets perform better |
Based on monthly moving average KP Tissue is performing at about 19% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of KP Tissue by adding it to a well-diversified portfolio.
KP Tissue Fundamentals Growth
KPT Stock prices reflect investors' perceptions of the future prospects and financial health of KP Tissue, and KP Tissue fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on KPT Stock performance.
| Return On Equity | 0.0437 | |||
| Current Valuation | 89.15 M | |||
| Shares Outstanding | 9.99 M | |||
| Price To Earning | (175.52) X | |||
| Price To Book | 1.29 X | |||
| EBITDA | 238.61 M | |||
| Total Debt | 1.8 M | |||
| Book Value Per Share | 6.90 X | |||
| Earnings Per Share | 0.30 X | |||
| Total Asset | 71.31 M | |||
| Retained Earnings | (116.67 M) | |||
About KP Tissue Performance
By examining KP Tissue's fundamental ratios, stakeholders can obtain critical insights into KP Tissue's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that KP Tissue is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in North America. KP Tissue Inc. was founded in 2012 and is headquartered in Mississauga, Canada. KP TISSUE operates under Household Personal Products classification in Canada and is traded on Toronto Stock Exchange.Things to note about KP Tissue performance evaluation
Checking the ongoing alerts about KP Tissue for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for KP Tissue help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| On 15th of July 2025 KP Tissue paid C$ 0.18 per share dividend to its current shareholders |
- Analyzing KP Tissue's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether KP Tissue's stock is overvalued or undervalued compared to its peers.
- Examining KP Tissue's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating KP Tissue's management team can have a significant impact on its success or failure. Reviewing the track record and experience of KP Tissue's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of KP Tissue's stock. These opinions can provide insight into KP Tissue's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in KPT Stock
KP Tissue financial ratios help investors to determine whether KPT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KPT with respect to the benefits of owning KP Tissue security.